News

Bend Research installs its first commercial-scale spray dryer at its Oregon facility.

DCAT's Sharp Sourcing 2014 educational program offers pharmaceutical and biopharmaceutical companies a forum to gain best practice insights in sourcing and procurement.

John Hopkins and UCSF-Stanford join FDA?s Centers of Excellence in Regulatory Science and Innovation.

FDA finalizes guidance on expedited programs for new drug approvals for treatment of serious and life-threatening conditions.

The CPhI report warns that Turkey's dynamism is being restricted by the current government reimbursement model.

ASCO meeting attendees give artistic interpretations of cancer journeys in the form of public Hope Murals.

Bristol-Myers Squibb announced collaborations with CytomX on probodies and with Incyte in an immunotherapy clinical trial.

The 11th Annual Global Biomanufacturing Study includes a global analysis of 238 biomanufacturers and 178 suppliers in 31 countries.

The Bulk Pharmaceuticals Task Force asks FDA to respond to concerns about reduction in API facility compliance inspections.

Actavis develops a solid dosage manufacturing and packing facility at its Manati site in Puerto Rico.

EquipNet announced its 15th year of supplying asset management services.

DPx Holdings B.V. donated $110,000 to more than 20 different hospitals and organizations across the globe.

The EDQM grants Gnosis a CEP for teicoplanin, a true fermentation glycopeptide antibiotic produced by actinoplanes teichomyceticus strains.

Pfizer and the Avon Foundation for Women Breast Cancer Grants Program will award up to $1 million in grants to advocacy, academic, and other not-for-profit organizations.

The Philippines pharmaceutical market value is expected to increase from approximately $4.3 billion in 2013 to $8 billion by 2020.

Avantor Performance Materials appoints Michael Stubblefield as CEO.

GSK reports 5-year vaccine price freeze for countries graduating from GAVI Alliance.

FDA targets illegal online pharmacies that sell unapproved prescription drugs to US consumers.

GE Healthcare launches the Xuri IL-2 for the activation and expansion of T-lymphocytes.

Merck KGaA fill-finish expansion in Italy will be completed in 2017.

Cytovance Biologics and Selexys Pharmaceuticals enter an agreement for development of clinical trial materials.

PhRMA announces 119 new medicines are in development to treat mental and addictive disorders.

Brookfield continues to supply viscometers and rheometers for laboratory and on-line process control applications.

Pfizer will submit a NDA with FDA for palbociclib, a treatment for locally advanced or metastatic breast cancer.

SAFC offers commercial and pilot-scale continuous-flow capacity.

FDA approves Entyvio, an injection to treat adult patients with moderate to severe ulcerative colitis and Crohn's disease.

BMS and AbbVie receive FDA breakthrough therapy designation for elotuzumab, an investigational humanized monoclonal antibody for multiple myeloma.

Novartis settles its litigation with the US subsidiary of Sun Pharma regarding Gleevec.

Meissner moves into its new headquarters in Camarillo, California.

FDA issues complete response letter for Novartis' RLX030 for acute heart failure.